Earnings Feed
Start Free
Home/Filings/4/0001209191-12-045055
4//SEC Filing

SCHRECK STEFAN 4

Accession 0001209191-12-045055

CIK 0001013606other
View on SEC.govCompany Profile

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 3:10 PM ET

Size

5.3 KB

Accession

0001209191-12-045055

Insider Transaction Report

Form 4
Period: 2012-09-09
ENDOLOGIX INC /DE/ELGX
SCHRECK STEFAN
Vice President
Transactions
  • Award

    Common Stock

    2012-09-09$12.62/sh+28,944$365,273→ 155,080 total
Footnotes (4)
  • [F1]25% vesting to occur upon the achievement of Nellix device revenue target for a month.
  • [F2]25% vesting to occur upon U.S. regulatory approval of Nellix device.
  • [F3]25% vesting to occur upon U.S. regulatory approval of Ventana device.
  • [F4]25% vesting to occur upon U.S.regulatory approval of a second-generation AFX device.

Documents

1 file

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

→
Entity typeother

Related Parties

1
  • filerCIK 0001282573

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 3:10 PM ET
Size
5.3 KB
View on SEC.gov